Linkcelltx
Founded 2022 · 27 employees on LinkedIn · 2 known investors
Link Cell Therapies is a biotechnology company developing logic-gate LINK CAR-T cell therapies aimed at treating solid and liquid tumors. It works in the cancer immunotherapy space and has a strategic collaboration with Johnson & Johnson.
Founders & leadership
Linkcelltx was founded in 2022 by Robbie Majzner and Crystal Mackall.
Investors · 2
Competitors · 2
by search overlap
Lyell33 shared keywordsLyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.
Kite Pharma32 shared keywordsKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Companies competing with Linkcelltx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Linkcelltx do?
- Link Cell Therapies is a biotechnology company developing logic-gate LINK CAR-T cell therapies aimed at treating solid and liquid tumors. It works in the cancer immunotherapy space and has a strategic collaboration with Johnson & Johnson.
- Who founded Linkcelltx?
- Linkcelltx was founded by Robbie Majzner, Crystal Mackall in 2022.
- Who are Linkcelltx's investors?
- Linkcelltx's investors include Samsara BioCapital, Wing.